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 Abstract  
The capacity to infer the mental states of others (known as “cognitive empathy”) is essential for 
social interactions, and a well-known theory proposes that it is negatively affected by intrauterine 
testosterone exposure. Furthermore, previous studies reported that testosterone administration 
impaired cognitive empathy in healthy adults, and that a biomarker of prenatal testosterone 
exposure (finger digit ratios) moderated the effect. However, empirical support for the 
relationship has relied on small-sample studies with mixed evidence. We investigate the 
reliability and generalizability of the relationship in two large-scale double-blind placebo-
controlled experiments in young men (N=243 and N=400), using two different testosterone 
administration protocols. We find no evidence that cognitive empathy is impaired by testosterone 
administration or associated with digit ratios. With an unprecedented combined sample size, 
these results counter current theories and previous high-profile reports, and demonstrate that 
previous investigations of this topic have been statistically underpowered. 
 
Key words: testosterone, cognitive empathy, mind reading, prenatal priming, steroid hormones, 
pharmacology  
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 1 
There is a growing scientific focus on the biological basis of social aptitudes and investigating 
the causes of their deficits (Ferguson, Young, & Insel, 2002). One important element of social 
cognition is “cognitive empathy”, that constitutes the capacity to infer the emotions, beliefs, and 
goals of others. Cognitive empathy impairments characterize a broad range of 
psychopathological conditions, and are a part of the clinical diagnostic criteria for autism 
spectrum disorders (ASDs) (American Psychiatric Association, 2013).1  
Testosterone-based biological theory of social cognition 
A popular biopsychological model known as the Extreme Male Brain (EMB) hypothesis (Baron-
Cohen, 2002) proposes that two distinct cognitive styles, “systemizing” and “empathizing”, 
typify males and females respectively. The stereotypically male systemizing domain has no 
social dimension, and in its extreme form social cognition is fully diminished. Guided by 
observations that ASDs emerge early in life and are substantially more prevalent among males2, 
and that males typically score lower than females in tests of cognitive empathy (Baron-Cohen, 
Wheelwright, Hill, Raste, & Plumb, 2001), the EMB hypothesis proposes that elevated prenatal 
exposure to the sex steroid testosterone (T) causes impairments in cognitive empathy, through its 
masculinizing effect on the developing brain (Zuloaga, Puts, Jordan, & Breedlove, 2008).  
The EMB hypothesis found evidential support in a study that reported a correlation between 
amniotic T levels and ASD traits ((Auyeung et al., 2009), though see (Kung et al., 2016)), and 
has remained popular yet controversial to date. Much of its research has relied on the assumption 
that the ratio between the hand’s second (index) to fourth (ring) digit (known as 2D:4D) is a 
                                                      
1
 The DSM V criteria for ASDs include “Non-verbal communication problems, such as abnormal eye contact, 
posture, facial expressions, tone of voice and gestures, as well as an inability to understand these.”  
2
 ASD incidence rates vary widely by study, from 5.2 to 72.6 per 10,000 people and ratios range from 1.81 to 15.7 
male:female.  
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 2 
developmental proxy for prenatal T exposure (Manning, 2002), which motivated examinations of 
correlations between 2D:4D and cognitive empathy and ASDs occurrences. While some studies 
provided supporting evidence (e.g., (Lutchmaya, Baron-Cohen, Raggatt, Knickmeyer, & 
Manning, 2004)), several others failed to detect a relationship (Guyatt, Heron, Le Cornu, 
Golding, & Rai, 2015; Hönekopp, 2012). Moreover, because it is not feasible to experimentally 
manipulate prenatal T exposure in humans (due to ethical considerations), findings along this 
line of research have been correlational, which cannot establish causal relations (Auyeung et al., 
2009). 
Testing testosterone’s causal effect on cognitive empathy 
A handful of experiments (see Table 1) attempted to address the above limitation by testing the 
effects of T administration on cognitive empathy in neurotypical adults, and investigating the 
dependency of these effects on the 2D:4D biomarker (Bos et al., 2016; Carré et al., 2015; Olsson, 
Kopsida, Sorjonen, & Savic, 2016; van Honk et al., 2011). This line of research critically relies 
on an assumption originating in animal research, that in utero androgen exposure moderates the 
activational effect of T (Zheng & Cohn, 2011). The seminal publication along this line of 
research reported a placebo-controlled within-subject experiment of 16 healthy females, in which 
exogenously administered T strongly impaired cognitive empathy measured using the “Reading 
the Mind in the Eyes Test” (RMET), a 36-item battery testing the ability to infer others’ 
emotional states and intentions from pictures of their eye regions (Baron-Cohen et al., 2001) (see 
Fig. S2 in Supplementary Material available online for example item). More than 50% of the 
individual differences in the effect of exogenous T on the RMET were explained by the 
participants’ variation in the right-hand 2D:4D, implying involvement of prenatal T exposure in 
the causal effect (van Honk et al., 2011).  
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A similar experiment with roughly twice the sample size (N=33) found a much smaller3 effect 
(P=0.048, one-tailed), and no moderation by 2D:4D (Olsson et al., 2016). A third experiment of 
16 females found neither a main effect nor a moderation by 2D:4D (Bos et al., 2016). Last, one 
experiment investigated the effect of T administration on the RMET in 30 healthy males and 
found neither a main effect nor a moderation by the right-hand 2D:4D; however, analysis 
revealed that T administration reduced cognitive empathy in participants with relatively low (but 
not high) left-hand 2D:4D (Carré et al., 2015). 
Do the data support the hypothesis? 
While these initial findings seem promising, they are subjected to important limitations. First, 
only one of the four studies rejected the null hypothesis with a 95% confidence for a main effect 
of T on the RMET (van Honk et al., 2011). Moreover, the seminal publication’s report of a 
strong moderating role of the right-hand 2D:4D was not replicated in any of the other studies 
(see Table 1).4  
A second concern is statistical power. Although the RMET is a noisy psychological instrument,5 
and 2D:4D is, at best, a noisy proxy of prenatal T exposure (Berenbaum, Bryk, Nowak, Quigley, 
& Moffat, 2009), all samples ranged between 16 and 33 participants, which might have been too 
meager to credibly estimate a true effect size. It is therefore impossible to know whether the 
inconsistencies in the literature are due to an absence of a true association, or the result of false 
                                                      
3
 The primary publication (van Honk et al. 2011) had a statistical power of only 0.26 to detect the effect size found 
in the similar study with twice the sample size (Olsson et al. 2016). 
4
 One experiment (in males) reported a statistically significant moderating effect, but only for the left-hand 2D:4D; 
the two other experiments reported no moderation of the 2D:4D (Bos et al., 2016).  
5
 The RMET has a test-retest reliability of 0.7 (Baron-Cohen et al., 2001). 
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negative findings due to low statistical power. Thus, these inconsistent results necessitate 
clarification through additional studies. 
To this end, we conducted a powerful direct test of the activational and developmental effects of 
T on cognitive empathy in two studies of healthy young men with 15 and 25 times the sample 
size conducted in females (van Honk et al. 2011) and 8 and 12 times the largest experiment in 
males (Carré et al., 2015), respectively, constituting the two largest behavioral T administration 
experiments conducted to date. In both studies we used a computer-based version of the RMET 
to test the hypothesis that T administration and its purported developmental biomarkers affects 
cognitive empathy.  
Methods 
Experiment 1 
Participants and experimental procedure. Two hundred forty-three males aged 18 to 55 
(M=23.63, SD=7.22) participated in the study and were mostly private Southern California 
consortium students from diverse ethnic backgrounds (see Participants section and Table S1a in 
Supplementary Material). The institutional review boards of Caltech and Claremont Graduate 
University approved the study, all participants gave informed consent, and no adverse events 
occurred. All data and materials are available on the Open Science Framework 
(https://osf.io/hztfe/).  
Participants registered by their preferred session dates and were added to cohorts of 13 to 16. 
They arrived at the lab at 9 a.m., signed informed consent forms, and had both of their hands 
scanned before being randomly assigned to private cubicles where they completed demographic 
and mood questionnaires and provided an initial saliva sample by passive drool (see 
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Supplementary Material). Next, participants proceeded to gel application (further details below), 
after which they were given printed material containing precautions and instructions prior to 
dismissal (experimental timeline shown in Fig. 1). All participants returned to the lab at 2 p.m., 
provided a second saliva sample, and began a battery of tasks which lasted approximately two 
hours. We did not randomize the order of the behavioral tasks, in similar fashion to previous 
studies (Zethraeus et al., 2009), to standardize hormonal measurements (which have diurnal 
cycles) among participants. Following the experiment, participants completed an exit survey, 
where they indicated their beliefs about the treatment they had received using a five-point scale. 
Treatment administration. Following initial intake, participants were escorted in groups of two 
to six to a semiprivate room. There they were provided en masse small plastic cups containing 
either 10 g of topical T that is a widely prescribed transdermal T gel with clearly mapped 
pharmacokinetics (Eisenegger, von Eckardstein, Fehr, & von Eckardstein, 2013) (100 mg, 
VogelxoTM, N=123) or volume equivalent of inert placebo of similar viscosity and texture 
placebo (80% alcogel, 20% Versagel®, N=118) under a double-blind protocol (see Fig. S1a in 
Supplementary Material for randomization protocol). Participants were instructed to apply the 
entirety of the gel container following manufacturer instructions. 
Saliva samples. Each participant provided four passive drool saliva samples (upon arrival prior 
to treatment administration, shortly after returning for afternoon session, another closely 
following the RMET, and a final sample prior to exit survey) for subsequent assay (see 
Supplemental Material for precise timing). To allow robust manipulation checks and obtain 
statistical control for hormonal markers of participants’ biological states, we used liquid 
chromatography tandem mass spectrometry (LC-MS/MS, detection levels and precision are 
available in Supplementary Material Table S2) to measure the following salivary steroids: 
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estrone, estradiol, estriol, T, androstenedione, DHEA, 5-alpha DHT, progesterone, 17OH-
progesterone, 11-deoxycortisol, cortisol, cortisone, and corticosterone (see Supplemental 
Material Table S7 for measurements).  
Digit Ratio Measurements. Participants’ hand scans acquired at intake were measured by two 
independent raters using and digital calipers to quantify 2D:4D; inter-rater correlation was 0.96 
and their scores were averaged. 
Behavioral task. We administered the adult version of the RMET developed by Baron-Cohen 
and colleagues (Baron-Cohen et al., 2001) which shows the eye region of an actor’s face, and a 
list of four words that describe emotional states and cognitive processes among which 
participants select the one that best described the person in the image (see Fig. S2  in the 
Supplemental Material for example item). The task was divided into two segments, baseline 
(morning) and post-treatment (afternoon), in a repeated measures design (see Fig. 1 below): each 
participant completed a half of the RMET in the morning (either part “A”, items 1-18, or part 
“B”, items 19-36) prior to receiving treatment, and the other half following treatment when, 
according to published pharmacokinetics, androgen levels are elevated and stable following 
exogenous application.  
Psychological Questionnaires. We measured mood using the PANAS-X scale (Watson & 
Clark, 1999), both pre- and post-treatment (see Table S1a in Supplementary Material for 
aggregated responses). 
Figure 1. Experimental Timelines 
a. Experiment 1  b. Experiment 2  
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Time-coded experimental timeline shows that, following 
intake (morning), participants completed half of the RMET 
(portion A or B), provided a saliva sample, and received gel 
prior to being dismissed. Upon their return to the lab 
(afternoon), another saliva sample was collected prior to 
taking the second portion of the RMET (B or A) (Standard 
errors shown).  
Timeline generalizes experimental sequence for all three start 
times for Experiment 2. Following arrival and completion of 
consent and self-report questionnaires, participants provided a 
saliva sample approximately 30 minutes prior to drug 
administration. The second sample was collected at the end of 
a two-hour protocol approximately one-and-a-half hours after 
drug administration and fifteen minutes after the RMET. 
 
Experiment 2 
Participants. Experiment 2 included both students and general public for a total of 400
participants (M=22.80, SD=4.68). The sample was composed of males with low ethnic
heterogeneity representative of the region (see Participants section and Table S1b in
Supplementary Material). All accepted participants completed the task and were included in the
analysis (For pre-screening criteria see Supplementary Material). The Nipissing University
Research Ethics Board approved this study and no harms or adverse events occurred. 
Experimental procedure. Participants arrived at one of three testing session times (10:00 a.m.,
12:30 p.m., or 2:30 p.m.) in cohorts of six and brought individually into private testing rooms to
read and sign an informed consent form, receive a participant number, and complete
questionnaires. Afterwards, participants provided a 1-2 ml saliva sample before treatment
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administration, after which they had their photos taken and hands scanned. Approximately two 
hours after arrival to the lab and one-and-a-half hours after drug administration participants 
completed the RMET then provided their final saliva sample. Upon session completion, 
participants received compensation and completed an exit survey asking which treatment they 
believed they had received (see Figure S1b in Supplementary Material).  
Treatment administration. Following initial saliva sample collection, a researcher provided 
two syringes pre-filled by a pharmacist following a double-blind protocol each containing 5.5 mg 
of either placebo or T gel (for a total of 11 mg). This is a newly-approved nasal gel used for the 
treatment of hypogonadism. Pharmacokinetic data indicate that serum T concentrations rise 
sharply within 15 mins of testosterone gel application and remain elevated (relative to placebo) 
up to 180 mins post-application (Geniole SN, Procyhyn TL, Marley N, Or...). The gel was either 
Natesto® or the volume equivalent of an inert placebo of similar viscosity and texture. Random 
assignment was determined such that half the participants in every group received T and half 
received placebo such that total participants base was bisected with N=200 for both T and 
placebo groups (see Fig. S1b in Supplementary Material for randomization protocol).  
Saliva samples. Each participant provided two saliva samples, with the first sample collection 
time 30 minutes following arrival (and prior to gel application), and the second 120 minutes after 
arrival. Participants provided passive drool into a 5 ml polystyrene tube while situated in their 
individual testing rooms as instructed by a research assistant and samples were analyzed for pre- 
and post-treatment T and baseline cortisol using commercially available enzyme immunoassay 
kits (DRG International) (see Table S2b in Supplementary Material for hormone measures).  
Digit Ratio Measurements. Participants’ 2D:4D were measured by two independent raters 
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using hand scans and digital calipers with an inter-rater correlation of 0.86. 
Behavioral task. Participants evaluated all 36 items of the RMET (Baron-Cohen et al., 2001) as 
a single task. 
Comparison of experimental features to van Honk et al. (2011) 
We note several differences between our study and the primary positive report of T 
administration on the RMET in 16 females (van Honk et al., 2011). 
Participant Sex. The EMB theory does not make any sex-specific predictions regarding the 
developmental and activational effects of T on cognitive empathy. However, van Honk et al. 
(2011) conducted their study in a female-only sample because the pharmacokinetics of a single 
dose of T had only been studied in females at the time (van Honk et al., 2011): “We exclusively 
recruited women because the parameters … for inducing neurophysiological effects … are 
known in women but not in men.” (p. 3450). The recent pharmacokinetic mappings for short-
term single dose T administrations (Carré et al., 2015; Eisenegger et al., 2013) and availability of 
two unique administration modalities of FDA-approved exogenous T provided us with a reliable 
foundation for testing the EMB hypothesis in men.  
Drug dosage and delivery. van Honk et al. (2011) used a sublingual T administration 
procedure, which causes a sharp increase in serum T of 10-fold or more within 15 minutes, with 
a rapid decline to normal levels within 90 minutes in women (Tuiten et al., 2000). It is important 
to note that the pharmacokinetic data for sublingual administration (published in Fig. 1 of Tuiten 
et al. (2000)) show that at the time the task was performed—4 hours after sublingual 
administration—participants’ T levels were the same across the T and placebo groups. Moreover, 
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the study that served as a justification for using a 4 hour delay had only 8 participants, and 
reported a statistically weak treatment effect (p=0.04, uncorrected for multiple comparisons). 
In Experiment 1 we chose to administer T using topical gel as this was the only T administration 
method for which the pharmacokinetics of a single-dose had been investigated at the time 
(Eisenegger et al., 2013). That study demonstrated that plasma T levels peaked 3 hours after 
single-dose exogenous topical administration, and that T measurements stabilized at high levels 
during the time window between 4 and 7 hours following administration. Therefore, we had all 
participants return to the lab 4.5 hours after receiving gel, when androgen levels were elevated 
and stable. We used a 100 mg transdermal dose, which quickly elevates then holds T levels high 
and stable for approximately 24 hours (Swerdloff et al., 2000) and was shown to generate effects 
on cognition, decision making, and other behaviors (Nadler et al. 2017; Nave et al. 2017; Nave et 
al. 2018).   
In Experiment 2 we used nasal delivery, following a recent study indicating that serum T 
concentrations rise sharply within 15 minutes after Natesto® gel application and remain elevated 
for approximately three hours post application among hypogonadal males (Geniole SN, 
Procyhyn TL, Marley N, Or...) (see Fig. S3 in Supplementary Material). This method conforms 
to our experimental paradigm’s pharmacokinetic structure as serum T approached its zenith in 
treated participants as they completed the RMET (see Supplementary Material Tables S2a and b 
for T levels).  
The doses in both experiments are commonly prescribed daily to men with low circulating T 
levels and serve as two distinct physical transport channels (transdermal and intranasal, 
respectively). Although it is less than the 150 mg used in one study (Carré et al., 2015), T levels 
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followed a similar pharmacokinetic arc (see Fig. 1). Various studies show significant 
heterogeneity in change in T levels depending on delivery method, location of application in the 
body, and biofluid measured.  
Experimental designs. van Honk et al. (2011) used the same questions in pre- and post-
treatment testing. As T treatment might affect participants’ capacity to recall answers (Cherrier, 
Craft, & Matsumoto, 2003), this design choice might have introduced memory confounds,. In 
Experiment 1 we divided the RMET into two portions, and administered each portion as either 
pre- or post-treatment measure in, allowing us to capture baseline abilities while ruling out such 
confounds. In Experiment 2 we conducted a between-subjects experiment that removes all 
effects of practice and recall from the data. 
 
Results 
 
Manipulation check 
T treatment resulted in higher saliva T values in the treatment groups compared with the placebo 
groups in both experiments (see Fig. 1 and Tables S2a and S2b in Supplementary Material). 
Consistent with previous reports, we found no treatment effects on mood and treatment 
expectancy (e.g., (Eisenegger, Naef, Snozzi, Heinrichs, & Fehr, 2010)), or levels of other 
hormones unaffected by exogenous T, as measured by LC-MS/MS in Experiment 1 or enzyme 
immunoassay in Experiment 2.  
Influence of T on RMET scores 
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Overall RMET scores in our samples were comparable with previous studies of similar
populations (see Fig. 2A below). Figure 2B shows baseline and post-treatment RMET scores in
Experiment 1, separated by treatment group and order. As expected, baseline (morning) RMET
performance were reliably correlated with afternoon scores (r(241)=0.40, P<0.001). In addition,
participants’ scores were, on average, slightly higher in the B portion of the test (A portion
average=13.54, SD=2.43; B portion average=13.95, SD=2.19, t(241)=2.53, P=0.01). Figure 2C
shows Experiment 2 scores by treatment groups.  
 
Figure 2. RMET distributions and scores across treatment groups  
 
Fig. 2. (A) Cumulative distributions of scores from our experiments juxtaposed with the original paper (Baron-
Cohen et al., 2001); scores for Experiment 1 portions A and B (both of which are unaffected by treatment) are 
combined into a total score: RMET scores in Experiment 1 was 27.5 (SD=3.9), and 25.6 (SD=3.9) in Experiment 
2, which are similar to male students in (Baron-Cohen et al., 2001) showing average score of 27.3 (SD=3.7). (B) 
Experiment 1 pre- and post-treatment RMET scores. No pre- or post-treatment differences were found between 
the two groups, regardless of the order in which portions of the tests were taken (standard errors shown). (C) 
Experiment 2 RMET scores. No differences were found between treatment groups.  
To test for the main effect of T administration on cognitive empathy for Experiment 1, we
estimated linear regression models with the post-treatment (afternoon) RMET score as the
dependent variable, a binary treatment indicator (T=1, placebo=0) as the independent variable of
primary interest, controlling for baseline performance, the order of the two portions of the RMET
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(A and B) and additional control variables6 (the results remain unchanged when these control 
variables are excluded from the models; see Tables S3a and S4a in Supplementary Material). 
Analogously, Experiment 2 data were analyzed using linear models with total RMET score as 
the dependent variable, a binary treatment indicator as the chief independent variable of interest, 
and control variables7 (results remain unchanged with their exclusion from the models; see 
Supplementary Material Tables S3b and S4b).  
We found no reliable effect of T administration on the RMET in Experiment 1 (beta=0.11, 95% 
CI=[−0.45, 0.68]; t(237)=0.37, P=0.71; Cohen’s d=0.04, 95% CI=[−0.19, 0.28]), and the effect’s 
point estimate was positive. These results rule out a negative effect size of T administration on 
the RMET that is greater in magnitude than d=0.19 with 97.5% confidence. A sample of at least 
870 participants (in a between-subject design), or 435 subjects (in a within-subject design), 
which is over 26 to 54 (within-subject 13 to 26) times greater than previous investigations, would 
be required to reliably detect even this “optimistic” negative effect size estimate with statistical 
power of 0.8. Regression analyses with comprehensive controls corroborate the absence of a 
main treatment effect, and the absence of moderation by 2D:4D (right hand, left hand, and their 
average), as implied by insignificant interaction coefficients (see Supplementary Material, Table 
S3a). Furthermore, in an analysis analogous to the previous positive report (van Honk et al., 
2011), we found no correlation between the treatment effect on the RMET and the right-hand 
                                                      
6
 These include RMET baseline scores, portion A or B, 2D:4D and treatment interactions, Cognitive Reflection 
Task (CRT) scores, math abilities, mood and affective measures, treatment expectancy, age, marital status, sexual 
preference, and all other measured hormones that were not influenced by T treatment. The CRT control was added 
because performance is impaired by exogenous T (Gideon Nave, Nadler, Zava, & Camerer, 2017) and people with 
ASD outperform non-ASD age-matched controls (Brosnan, Lewton, & Ashwin, 2016).  
7
 These include Cognitive Reflection Task (CRT) scores, factor 1 and 2 psychopathy measures, treatment 
expectancy, age, marital status, sexual preference, and all other measured hormones that were not influenced by T 
treatment.  
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2D:4D in the T group (r(123)=0.04, P=0.66, 95% CI=(−0.138, 0.215)) (see Fig. S4 in the 
Supplementary Material).  
Experiment 2, which had 400 participants, could also not reject the null hypothesis (beta=0.27, 
95% CI=[−0.49, 1.02]; t(398)=0.69, P=0.49; Cohen’s d=0.04, 95% CI=[−0.15, 0.24]) and there 
was no significant treatment effect in any regression model (Supplementary Material Tables S3b 
and S4b). Similarly, the point estimate of the effect in Experiment 2 was positive, and our results 
rule out a negative effect size of T administration on the RMET that is greater in magnitude than 
0.15 with 97.5% confidence. A sample of at least 1,394 participants (in a between-subject 
design), or 697 subjects (in a within-subject, cross-over design), which is 42 to 87 times greater 
than previous investigations would be required to reliably detect the lower negative bound of the 
stated effect size.  
Further analyses of each question in isolation using Chi-squared tests revealed no systematic 
differences between treatment conditions in any of the RMET items in both experimental 
datasets (see Supplementary Material Tables S5a and b). 
Testing for effect of 2D:4D  
Prenatal T proxies (the 2D:4D, either right-hand, left-hand, or their average) did not correlate 
with RMET scores in both experiments or moderate the effect of T administration, echoing other 
recent findings (Bos et al., 2016; Carré et al., 2015; Olsson et al., 2016) (see Supplementary 
Material Tables S3a-S4b). These results are in line with previous reports showing no correlation 
between the 2D:4D and RMET scores (Hönekopp, 2012; Masuya et al., 2015; Voracek & 
Dressler, 2006), and in contrast to the two papers reporting an interaction between 2D:4D and 
the exogenous T’s effect on the RMET (Carré et al., 2015; van Honk et al., 2011). As noted 
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above, the two latter reports are inconsistent with each other, with one reporting a moderation of 
the right-hand 2D:4D and the other reporting a moderation of only the left-hand 2D:4D. 
Discussion 
Our experiments used two notably large samples to test the effects of pharmacological T 
manipulation on cognitive empathy. Despite experimental differences between them, their 
collected data exhibit the same results with robust statistical consistency, to demonstrate a lack 
of effects of T administration and 2D:4D on cognitive empathy. These findings, and the literature 
as a whole, cast serious doubts on the proposal that T causally impairs cognitive empathy, for 
several reasons. 
First, the low statistical power of previous investigations undermines their reliability in capturing 
true effects. Even if we assume that a purported size of T’s negative effect on cognitive empathy 
is the overly “optimistic” negative bound of our confidence intervals, we find that all previous 
investigations of the topic were statistically underpowered (< 0.3 power) (see Table 1 and 
Supplementary Material Power Calculations section).  
Second, the results of the previous small sample studies’ are discrepant. Our large samples draw 
on drastically more data than all previous investigations combined, and generalize across 
geographically, economically, and culturally distinct populations (see Participants section of 
Supplementary Material). Our use of two different experimental designs and T administration 
protocols across these populations further mitigates the concern that the outcomes were due to a 
particular experimental factor. Of note, there are some design differences between our studies 
and previous investigations (see Table 1; differences from van Honk et al. (2011) discussed 
above). However, even if those design differences led to a complete abolishment of a “real” 
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effect of T on cognitive empathy, our results demonstrate beyond a reasonable doubt that such an
effect is not generalizable.  
Table 1. Summary of literature linking T administration and the RMET 
 
Design Sex N Design Dose Main 
effect 
Effe
ct 
Size 
SE of 
ES 
95 % CI 
for ES 
2D
mo
at
Nadler et al. 
Experiment 2 M 400 
Within 
subject; 
no repetition 
11 mg 
intranasal 
No effect; 
P = 0.66  
-
0.04 0.26 -0.24 
0.
15 N
Nadler et al. 
Experiment 1 M 241 
Between 
subject; 
no repetition 
100 mg 
transdermal 
No effect; 
P = 0.83 
-
0.03 0.36 -0.28 
0.
22 N
Olsson et al. 
(2016)  F 33 
Within 
subject; 
repeated 
task 
50 mg 
transdermal 
One-tailed 
P = 0.048; 
d = 0.32 
0.33 0.13 -0.15 0.82 N
Carré et al. 
(2015)  M 30 
Within 
subject 
150 mg 
transdermal 
No effect; 
P = 0.25 
-
0.20 0.35 -0.70 
0.
31 
L
ha
van Honk et 
al. (2011)  F 16 
Within 
subject;  
repeated 
task 
0.5 mg 
sublingual 
One-tailed 
Wilcoxon 
P = 0.01; d 
= 0.54 
0.49 0.25 -0.21 1.19 
R
ha
Bos et al. 
(2016)  F 16 
Within 
subject;  
no repetition 
0.5 mg 
sublingual 
No effect; 
P = 0.78  0.10 0.10 -0.60 
0.
79 
 
A third reason concerns the validity of the 2D:4D biomarker. The initial findings that prenatal T
exposure correlates with 2D:4D are supported in non-clinical and clinical human populations
(Lutchmaya et al., 2004), as well as in preliminary causal evidence in relative phalanx/tibia
lengths in mice (Zheng & Cohn, 2011). However, recent work highlights concerns regarding the
reliability of 2D:4D as a biomarker (Valla & Ceci, 2011). The 2D:4D of complete androgen
insensitivity syndrome patients were found to be only somewhat feminized, and had the same
variance as in healthy controls, demonstrating that the preponderance of individual differences in
the measure is not attributable to the influence of T exposure (Berenbaum et al., 2009). There is
also longitudinal evidence that 2D:4D systematically changes during childhood (McIntyre,
Ellison, Lieberman, Demerath, & Towne, 2005), which is unconformable with the preposition
that it accurately quantifies prenatal influences per se. Moreover, a study of the hunter-gatherer
 
:4D 
der
ion 
o 
o 
o 
eft 
nd 
ight 
nd 
– 
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Hadza people reported an absence of 2D:4D distinction between males and females, suggesting 
that sex differences in the measure are not universal (Apicella, Tobolsky, Marlowe, & Miller, 
2016). 
Many reports of correlations between 2D:4D and behavioral traits hold only for subsets of the 
population (e.g., particular sex or race). Correlation sometimes holds only for the right hand 
2D:4D but in other times only for the left hand, or for the average of both hands (Teatero & 
Netley, 2013). Overall, significant results are seldom replicated, and few survive correction for 
multiple comparisons or meta-analytic aggregations (e.g., (Turanovic, Pratt, & Piquero, 2017)). 
These concerns belie the validity of the measure as a biomarker and its capacity to detect reliable 
correlations with noisy psychological constructs in studies of small samples. 
Despite our dissenting results, the absence of evidence is not necessarily evidence of absence. 
Specifically, the lack of an association between 2D:4D and cognitive empathy could be 
attributable to the failure of the measure to serve as a reliable androgenic biomarker. We 
therefore agree with Baron-Cohen et al. (2011) (p. 6) that it is worthwhile to study the 
occurrence of impaired cognitive empathy and other ASD traits in developmentally unique 
populations. One such study reported mixed evidence of higher scores in some Autism Quotient 
self-rating subscales among women with congenital adrenal hyperlexia (CAH) and lower scores 
in other subscales, compared with their unaffected relatives (Knickmeyer et al., 2006), with no 
significant results in men. However, results along this line of research, too, are far from being 
conclusive. For example, (Kung et al., 2016) found that young females with and without CAH 
did not differ in autistic traits, and that amniotic T levels were not associated with scores from 
either sex individually or the entire sample. Other longitudinal studies also found no association 
between various measures of prenatal androgens measured in umbilical cord blood and amniotic 
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fluid and autistic traits (Jamnadass et al., 2015; Whitehouse et al., 2012). Thus, further 
investigations, preferably using larger samples, are required for resolving the inconsistencies in 
this literature. 
 
To conclude, we tested T’s causal role in cognitive empathy across distinct administration 
methods using notably large samples from two distinct populations, and found no evidence of an 
effect of T administration on RMET in young adult neurotypical males. While our results do not 
exclude all possible relationships between T and interpreting others’ emotions and states of 
mind, our large-scale study and evaluation of previous literature exhibit robust evidence of no 
causal relationship between activational and purported developmental T exposure and cognitive 
empathy.  
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